Botox (onabotulinumtoxinA)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
January 2016
WARNINGS AND PRECAUTIONS
Bronchitis and Upper Respiratory Tract Infections in Patients Treated for Spasticity
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts